Russia plans Covid-19 vaccine output at 6 million doses a month: RIA
Coronavirus chronicle
23 August, 2020, 05:40 pm
Last modified: 23 August, 2020, 05:40 pm
Large-scale testing of the vaccine, developed by Moscow’s Gamaleya institute, is due to start in Russia next week
FILE PHOTO: A handout photo shows vials during the production of "Gam-Covid-Vac" vaccine against the coronavirus disease (Covid-19), developed by the Gamaleya National Research Institute of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF), at Binnopharm pharmaceutical company in Zelenograd near Moscow, Russia August 7, 2020. The Russian Direct Investment Fund (RDIF)/Andrey Rudakov/Handout via REUTERS
Russia expects to produce between 1.5 million and 2 million doses per month of its potential Covid-19 vaccine by the year end, gradually ramping up production to 6 million doses a month, the RIA news agency cited industry minister Denis Manturov as saying on Sunday.
Large-scale testing of the vaccine, developed by Moscow's Gamaleya institute, is due to start in Russia next week.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.